The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study

dc.creatorSales, Henrique F
dc.creatorCerqueira, Caroline
dc.creatorVaz, Daniel
dc.creatorRios, Débora Medeiros
dc.creatorFranceschi, Giulia Armani
dc.creatorLucena, Pedro H
dc.creatorSternberg, Carla
dc.creatorNóbrega, Ana C
dc.creatorLuze, Cleber
dc.creatorFonseca, Danilo
dc.creatorCarvalho, Alessandra L
dc.creatorMonteiro, Larissa
dc.creatorSiqueira, Isadora Cistina de
dc.creatorBandeira, Igor D
dc.creatorLucena, Rita
dc.date.accessioned2020-11-11T11:35:31Z
dc.date.accessioned2023-09-05T15:05:04Z
dc.date.available2020-11-11T11:35:31Z
dc.date.available2023-09-05T15:05:04Z
dc.date.created2020-11-11T11:35:31Z
dc.date.issued2020
dc.identifierSALES, Henrique F. et al. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study. Neurological Research, 2020.
dc.identifier0161-6412
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/44371
dc.identifier10.1080/01616412.2020.1820698
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8663189
dc.languageeng
dc.publisherTaylor & Francis
dc.rightsopen access
dc.titleThe impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study
dc.typeArticle


Este ítem pertenece a la siguiente institución